ArticleFrontiers in pharmacology2022

Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes.

Umair Ilyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.